{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:15:36Z","timestamp":1740107736941,"version":"3.37.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T00:00:00Z","timestamp":1573862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T00:00:00Z","timestamp":1573862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005430","name":"P\u00e4ij\u00e4t-H\u00e4meen Rahasto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005430","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Reumatautien Tutkimuss\u00e4\u00e4ti\u00f6"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2020,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>Children with juvenile idiopathic arthritis (JIA) may be predisposed to serious pneumonia due to modern disease-modifying anti-rheumatic treatment. In this nationwide retrospective study with clinical data, we describe the pneumonia episodes among children with JIA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Patients under 18 years of age with JIA and pneumonia during 1998\u20132014 were identified in the National Hospital Discharge Register in Finland. Each individual patient record was reviewed, and detailed data on patients with JIA and pneumonia were retrieved, recorded, and analyzed. If the patient was hospitalized or received intravenous antibiotics, the pneumonia was considered serious.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>There were 157 episodes of pneumonia among 140 children with JIA; 111 episodes (71%) were serious (80% in 1998\u20132006 and 66% in 2007\u20132014). The mean age of the patients was 9 years. Forty-eight percent had active JIA and 46% had comorbidities. Disease-modifying anti-rheumatic drugs (DMARD) were used at the time of 135 episodes (86%): methotrexate (MTX) by 62% and biologic DMARDs (bDMARD) by 30%. There was no significant difference in the use of bDMARDs, MTX and glucocorticoids between the patient groups with serious and non-serious pneumonia episodes. During six of the episodes, intensive care was needed. Two patients (1.3%) died, the remaining ones recovered fully.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Although the incidence of pneumonia and the use of immunosuppressive treatment among children with JIA increased from 1998 to 2014, the proportion of serious pneumonias in these patients decreased. There was no significant difference in the use of anti-rheumatic medication between patients with serious and non-serious pneumonia.<jats:table-wrap><jats:table><jats:tbody><jats:tr><jats:td colspan=\"2\"><jats:bold>Key Points<\/jats:bold>\u2022 <jats:italic>The incidence of serious pneumonias decreased from 1998 to 2014 among children with juvenile idiopathic arthritis (JIA).<\/jats:italic>\u2022 <jats:italic>There was no significant difference in the use of the disease-modifying anti-rheumatic medication between JIA patients with serious and non-serious pneumonias.<\/jats:italic>\u2022 <jats:italic>Active JIA, comorbidities, and combination medication were associated with nearly half of the pneumonias.<\/jats:italic><\/jats:td><\/jats:tr><\/jats:tbody><\/jats:table><\/jats:table-wrap><\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10067-019-04804-x","type":"journal-article","created":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T02:02:49Z","timestamp":1573869769000},"page":"853-860","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Decreasing trend in the incidence of serious pneumonias in Finnish children with juvenile idiopathic arthritis"],"prefix":"10.1007","volume":"39","author":[{"given":"P\u00e4ivi H.","family":"Salonen","sequence":"first","affiliation":[]},{"given":"Juha H.","family":"Salonen","sequence":"additional","affiliation":[]},{"given":"Hanna","family":"S\u00e4il\u00e4","sequence":"additional","affiliation":[]},{"given":"Mika","family":"Helminen","sequence":"additional","affiliation":[]},{"given":"Miika","family":"Linna","sequence":"additional","affiliation":[]},{"given":"Markku J.","family":"Kauppi","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,11,16]]},"reference":[{"key":"4804_CR1","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S0140-6736(07)60363-8","volume":"369","author":"A Ravelli","year":"2007","unstructured":"Ravelli A, Martini A (2007) Juvenile idiopathic arthritis. Lancet 369:767\u2013778","journal-title":"Lancet"},{"key":"4804_CR2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s11926-015-0542-z","volume":"17","author":"G Horneff","year":"2015","unstructured":"Horneff G (2015) Biologic-associated infections in pediatric rheumatology. Curr Rheumatol Rep 17:66","journal-title":"Curr Rheumatol Rep"},{"key":"4804_CR3","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1002\/art.34458","volume":"64","author":"T Beukelman","year":"2012","unstructured":"Beukelman T, Xie F, Chen L et al (2012) Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment. Arthritis Rheum 64:2773\u20132780","journal-title":"Arthritis Rheum"},{"key":"4804_CR4","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/rheumatology\/kex049","volume":"57","author":"W Lee","year":"2018","unstructured":"Lee W, Lee TA, Suda KJ, Calip GS, Briars L, Schumock GT (2018) Risk of serious bacterial infection associated with tumour necrosis factor-alpha inhibitors in children with juvenile idiopathic arthritis. Rheumatology (Oxford) 57:273\u2013282","journal-title":"Rheumatology (Oxford)"},{"key":"4804_CR5","doi-asserted-by":"crossref","unstructured":"Davies HD (2016) Infectious complications with the use of biologic response modifiers in infants and children. Pediatrics 138","DOI":"10.1542\/peds.2016-1209"},{"key":"4804_CR6","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1002\/art.39197","volume":"67","author":"R Davies","year":"2015","unstructured":"Davies R, Southwood TR, Kearsley-Fleet L, Lunt M, Hyrich KL (2015) Medically significant infections are increased in patients with juvenile idiopathic arthritis treated with etanercept: results from the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study. Arthritis Rheum 67:2487\u20132494","journal-title":"Arthritis Rheum"},{"key":"4804_CR7","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13075-016-1109-8","volume":"18","author":"T Beukelman","year":"2016","unstructured":"Beukelman T, Xie F, Baddley JW et al (2016) The risk of hospitalized infection following initiation of biologic agents versus methotrexate in the treatment of juvenile idiopathic arthritis. Arthritis Res Ther 18:210","journal-title":"Arthritis Res Ther"},{"key":"4804_CR8","first-page":"502","volume":"36","author":"PH Salonen","year":"2018","unstructured":"Salonen PH, S\u00e4il\u00e4 H, Salonen JH, Linna M, Helminen M, Kauppi MJ (2018) Pneumonia in children with juvenile idiopathic arthritis in Finland 1999-2014: a nationwide retrospective register linkage study. Clin Exp Rheumatol 36:502\u2013507","journal-title":"Clin Exp Rheumatol"},{"key":"4804_CR9","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/acr.22961","volume":"69","author":"I Becker","year":"2017","unstructured":"Becker I, Horneff G (2017) Risk of serious infection in juvenile idiopathic arthritis patients associated with tumor necrosis factor inhibitors and disease activity in the German Biologics in Pediatric Rheumatology Registry. Arthritis Care Res 69:552\u2013560","journal-title":"Arthritis Care Res"},{"key":"4804_CR10","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/INF.0b013e3182833cbb","volume":"32","author":"A Woerner","year":"2013","unstructured":"Woerner A, Ritz N (2013) Infections in children treated with biological agents. Pediatr Infect Dis J 32:284\u2013288","journal-title":"Pediatr Infect Dis J"},{"key":"4804_CR11","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1093\/cid\/cir1065","volume":"54","author":"JAG Scott","year":"2012","unstructured":"Scott JAG, Wonodi C, Mo\u00efsi JC et al (2012) The definition of pneumonia, the assessment of severity, and clinical standardization in the Pneumonia Etiology Research for Child Health Study. Clin Infect Dis 54:S10\u2013S116","journal-title":"Clin Infect Dis"},{"key":"4804_CR12","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/acr.20497","volume":"63","author":"CA Wallace","year":"2011","unstructured":"Wallace CA, Giannini EH, Huang B, Itert L, Ruperto N (2011) American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis. Arthritis Care Res 63:929\u2013936","journal-title":"Arthritis Care Res"},{"key":"4804_CR13","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1542\/peds.2014-0331","volume":"134","author":"MI Neuman","year":"2014","unstructured":"Neuman MI, Hall M, Gay JC et al (2014) Readmissions among children previously hospitalized with pneumonia. Pediatrics 134:100\u2013109","journal-title":"Pediatrics"},{"key":"4804_CR14","doi-asserted-by":"publisher","first-page":"e0172690","DOI":"10.1371\/journal.pone.0172690","volume":"12","author":"AA Palmu","year":"2017","unstructured":"Palmu AA, Rinta-Kokko H, Nohynek H, Nuorti JP, Kilpi TM, Jokinen J (2017) Impact of ten-valent pneumococcal conjugate vaccine on pneumonia in Finnish children in a nation-wide population-based study. PLoS ONE 12:e0172690","journal-title":"PLoS ONE"},{"key":"4804_CR15","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1136\/annrheumdis-2014-205372","volume":"74","author":"J Guzman","year":"2015","unstructured":"Guzman J, Oen K, Tucker LB et al (2015) The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort. Ann Rheum Dis 74:1854\u20131860","journal-title":"Ann Rheum Dis"},{"key":"4804_CR16","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1186\/s12879-015-1162-y","volume":"15","author":"SI Pelton","year":"2015","unstructured":"Pelton SI, Shea KM, Farkouh RA et al (2015) Rates of pneumonia among children and adults with chronic medical conditions in Germany. BMC Infect Dis 15:470","journal-title":"BMC Infect Dis"},{"key":"4804_CR17","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1542\/hpeds.2015-0007","volume":"5","author":"KM Wilson","year":"2015","unstructured":"Wilson KM, Torok MR, Localio R et al (2015) Hospitalization for community-acquired pneumonia in children: effect of an asthma codiagnosis. Hosp Pediatr 5:415\u2013422","journal-title":"Hosp Pediatr"},{"key":"4804_CR18","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1097\/INF.0000000000000317","volume":"33","author":"JK Leyenaar","year":"2014","unstructured":"Leyenaar JK, Lagu T, Shieh M, Pekow PS, Lindenauer PK (2014) Management and outcomes of pneumonia among children with complex chronic conditions. Pediatr Infect Dis J 33:907\u2013911","journal-title":"Pediatr Infect Dis J"},{"key":"4804_CR19","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1056\/NEJMoa1405870","volume":"372","author":"S Jain","year":"2015","unstructured":"Jain S, Williams DJ, Arnold SR et al (2015) Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med 372:835\u2013845","journal-title":"N Engl J Med"},{"key":"4804_CR20","unstructured":"The National Institute of Health and Welfare (2018) The Finnish Register of Congenital Malformations 2014. http:\/\/www.thl.fi\/statistics\/congenitalmalformations"},{"key":"4804_CR21","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jpeds.2008.07.056","volume":"154","author":"H Juj","year":"2009","unstructured":"Juj H, Emery H (2009) The arthropathy of Down syndrome: an underdiagnosed and under-recognized condition. J Pediatr 154:234\u2013238","journal-title":"J Pediatr"},{"key":"4804_CR22","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1002\/acr.22053","volume":"65","author":"S Ringold","year":"2013","unstructured":"Ringold S, Grant S, Girdish C, Wallace CA, Sullivan SD (2013) Injectable tumor necrosis factor \u03b1 inhibitors and outpatient antimicrobial use in children with rheumatic diseases: analyses of prescription claims from a pharmacy benefit manager database. Arthritis Care Res 65:1880\u20131884","journal-title":"Arthritis Care Res"},{"key":"4804_CR23","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1093\/rheumatology\/ket256","volume":"52","author":"K Vidqvist","year":"2013","unstructured":"Vidqvist K, Malin M, Varjolahti-Lehtinen T, Korpela MM (2013) Disease activity of idiopathic juvenile arthritis continues through adolescence despite the use of biologic therapies. Rheumatology (Oxford) 52:1999\u20132003","journal-title":"Rheumatology (Oxford)"},{"key":"4804_CR24","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.3899\/jrheum.140012","volume":"41","author":"ML Mannion","year":"2014","unstructured":"Mannion ML, Xie F, Curtis JR, Beukelman T (2014) Recent trends in medication usage for the treatment of juvenile idiopathic arthritis and the influence of tumor necrosis factor inhibitors. J Rheumatol 41:2078\u20132084","journal-title":"J Rheumatol"},{"key":"4804_CR25","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1002\/art.30426","volume":"63","author":"E Nordal","year":"2011","unstructured":"Nordal E, Zak M, Aalto K et al (2011) Ongoing disease activity and changing categories in a long-term nordic cohort study of juvenile idiopathic arthritis. Arthritis Rheum 63:2809\u20132818","journal-title":"Arthritis Rheum"},{"key":"4804_CR26","first-page":"878","volume":"29","author":"H Pohjankoski","year":"2011","unstructured":"Pohjankoski H, Latva K, Kautiainen H et al (2011) First-year purchases of disease-modifying drugs of incident patients with chronic juvenile arthritis in Finland. Clin Exp Rheumatol 29:878\u2013881","journal-title":"Clin Exp Rheumatol"},{"key":"4804_CR27","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1093\/rheumatology\/keu457","volume":"54","author":"M Tarkiainen","year":"2015","unstructured":"Tarkiainen M, Tynj\u00e4l\u00e4 P, V\u00e4h\u00e4salo P, Lahdenne P (2015) Occurrence of adverse events in patients with JIA receiving biologic agents: long-term follow-up in a real-life setting. Rheumatology (Oxford) 54:1170\u20131176","journal-title":"Rheumatology (Oxford)"},{"key":"4804_CR28","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s10067-018-4367-9","volume":"38","author":"D Aygun","year":"2019","unstructured":"Aygun D, Sahin S, Adrovic A et al (2019) The frequency of infections in patients with juvenile idiopathic arthritis on biologic agents: 1-year prospective study. Clin Rheumatol 38:1025\u20131030","journal-title":"Clin Rheumatol"},{"key":"4804_CR29","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1002\/art.21568","volume":"54","author":"F Wolfe","year":"2006","unstructured":"Wolfe F, Caplan L, Michaud K (2006) Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: Associations with prednisone, disease-modifying antirheumatic drugs, and anti\u2013tumor necrosis factor therapy. Arthritis Rheum 54:628\u2013634","journal-title":"Arthritis Rheum"},{"key":"4804_CR30","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1093\/rheumatology\/keq242","volume":"50","author":"JB Galloway","year":"2011","unstructured":"Galloway JB, Hyrich KL, Mercer LK et al (2011) Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly. Rheumatology (Oxford) 50:124\u2013131","journal-title":"Rheumatology (Oxford)"},{"key":"4804_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/cid\/cir531","volume":"53","author":"JS Bradley","year":"2011","unstructured":"Bradley JS, Byington CL, Shah SS et al (2011) The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis 53:25","journal-title":"Clin Infect Dis"},{"key":"4804_CR32","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1097\/INF.0b013e318290bf63","volume":"32","author":"AL Myers","year":"2013","unstructured":"Myers AL, Hall M, Williams DJ et al (2013) Prevalence of bacteremia in hospitalized pediatric patients with community-acquired pneumonia. Pediatr Infect Dis J 32:736\u2013740","journal-title":"Pediatr Infect Dis J"},{"key":"4804_CR33","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.3201\/eid2210.151245","volume":"22","author":"M Abinun","year":"2016","unstructured":"Abinun M, Lane JP, Wood M, Friswell M, Flood TJ, Foster HE (2016) Infection-related death among persons with refractory juvenile idiopathic arthritis. Emerg Infect Dis 22:1720\u20131727","journal-title":"Emerg Infect Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04804-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-019-04804-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04804-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,15]],"date-time":"2020-11-15T00:44:50Z","timestamp":1605401090000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-019-04804-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,16]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["4804"],"URL":"https:\/\/doi.org\/10.1007\/s10067-019-04804-x","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2019,11,16]]},"assertion":[{"value":"5 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The coordinating ethics committee of Helsinki and Uusimaa Hospital District approved the study protocol (228\/13\/03\/00\/10) and the use of the Care Register for Health Care (HILMO) data.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}